Expression of pathogenic SCN9A mutations in the zebrafish

A model to study small-fiber neuropathy

on behalf of the PROPANE Study Group

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Small-fiber neuropathy (SFN) patients experience a spectrum of sensory abnormalities, including attenuated responses to non-noxious temperatures in combination with a decreased density of the small-nerve fibers. Gain-of-function mutations in the voltage-gated sodium channels SCN9A, SCN10A and SCN11A have been identified as an underlying genetic cause in a subpopulation of patients with SFN. Based on clinical-diagnostic tests for SFN, we have set up a panel of two read-outs reflecting SFN in zebrafish, being nerve density and behavioral responses. Nerve density was studied using a transgenic line in which the sensory neurons are GFP-labelled. For the behavioral experiments, a temperature-controlled water compartment was developed. This device allowed quantification of the behavioral response to temperature changes. By using these read-outs we demonstrated that zebrafish embryos transiently overexpressing the pathogenic human SCN9A p.(I228M) or p.(G856D) mutations both have a significantly decreased density of the small-nerve fibers. Additionally, larvae overexpressing the p.(I228M) mutation displayed a significant increase in activity induced by temperature change. As these features closely resemble the clinical hallmarks of SFN, our data suggest that transient overexpression of mutant human mRNA provides a model for SFN in zebrafish. This disease model may provide a basis for testing the pathogenicity of novel genetic variants identified in SFN patients. Furthermore, this model could be used for studying SFN pathophysiology in an in vivo model and for testing therapeutic interventions.

Original languageEnglish
Pages (from-to)257-264
Number of pages8
JournalExperimental Neurology
Volume311
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Zebrafish
Mutation
Temperature
Nerve Fibers
Voltage-Gated Sodium Channels
Small Fiber Neuropathy
Sensory Receptor Cells
Routine Diagnostic Tests
Larva
Virulence
Embryonic Structures
Equipment and Supplies
Messenger RNA
Water

Keywords

  • Nerve density
  • SCN9A mutations
  • Small-fiber neuropathy
  • Temperature assay
  • Zebrafish model

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Expression of pathogenic SCN9A mutations in the zebrafish : A model to study small-fiber neuropathy. / on behalf of the PROPANE Study Group.

In: Experimental Neurology, Vol. 311, 01.01.2019, p. 257-264.

Research output: Contribution to journalArticle

@article{6e8c7be4c5324abe9e1677ba979ba5b9,
title = "Expression of pathogenic SCN9A mutations in the zebrafish: A model to study small-fiber neuropathy",
abstract = "Small-fiber neuropathy (SFN) patients experience a spectrum of sensory abnormalities, including attenuated responses to non-noxious temperatures in combination with a decreased density of the small-nerve fibers. Gain-of-function mutations in the voltage-gated sodium channels SCN9A, SCN10A and SCN11A have been identified as an underlying genetic cause in a subpopulation of patients with SFN. Based on clinical-diagnostic tests for SFN, we have set up a panel of two read-outs reflecting SFN in zebrafish, being nerve density and behavioral responses. Nerve density was studied using a transgenic line in which the sensory neurons are GFP-labelled. For the behavioral experiments, a temperature-controlled water compartment was developed. This device allowed quantification of the behavioral response to temperature changes. By using these read-outs we demonstrated that zebrafish embryos transiently overexpressing the pathogenic human SCN9A p.(I228M) or p.(G856D) mutations both have a significantly decreased density of the small-nerve fibers. Additionally, larvae overexpressing the p.(I228M) mutation displayed a significant increase in activity induced by temperature change. As these features closely resemble the clinical hallmarks of SFN, our data suggest that transient overexpression of mutant human mRNA provides a model for SFN in zebrafish. This disease model may provide a basis for testing the pathogenicity of novel genetic variants identified in SFN patients. Furthermore, this model could be used for studying SFN pathophysiology in an in vivo model and for testing therapeutic interventions.",
keywords = "Nerve density, SCN9A mutations, Small-fiber neuropathy, Temperature assay, Zebrafish model",
author = "{on behalf of the PROPANE Study Group} and Ivo Eijkenboom and Maurice Sopacua and Otten, {Auke B.C.} and Gerrits, {Monique M.} and Hoeijmakers, {Janneke G.J.} and Waxman, {Stephen G.} and Raffaella Lombardi and Giuseppe Lauria and Merkies, {Ingemar S.J.} and Smeets, {Hubert J.M.} and Faber, {Catharina G.} and Vanoevelen, {Jo M.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.expneurol.2018.10.008",
language = "English",
volume = "311",
pages = "257--264",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Expression of pathogenic SCN9A mutations in the zebrafish

T2 - A model to study small-fiber neuropathy

AU - on behalf of the PROPANE Study Group

AU - Eijkenboom, Ivo

AU - Sopacua, Maurice

AU - Otten, Auke B.C.

AU - Gerrits, Monique M.

AU - Hoeijmakers, Janneke G.J.

AU - Waxman, Stephen G.

AU - Lombardi, Raffaella

AU - Lauria, Giuseppe

AU - Merkies, Ingemar S.J.

AU - Smeets, Hubert J.M.

AU - Faber, Catharina G.

AU - Vanoevelen, Jo M.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Small-fiber neuropathy (SFN) patients experience a spectrum of sensory abnormalities, including attenuated responses to non-noxious temperatures in combination with a decreased density of the small-nerve fibers. Gain-of-function mutations in the voltage-gated sodium channels SCN9A, SCN10A and SCN11A have been identified as an underlying genetic cause in a subpopulation of patients with SFN. Based on clinical-diagnostic tests for SFN, we have set up a panel of two read-outs reflecting SFN in zebrafish, being nerve density and behavioral responses. Nerve density was studied using a transgenic line in which the sensory neurons are GFP-labelled. For the behavioral experiments, a temperature-controlled water compartment was developed. This device allowed quantification of the behavioral response to temperature changes. By using these read-outs we demonstrated that zebrafish embryos transiently overexpressing the pathogenic human SCN9A p.(I228M) or p.(G856D) mutations both have a significantly decreased density of the small-nerve fibers. Additionally, larvae overexpressing the p.(I228M) mutation displayed a significant increase in activity induced by temperature change. As these features closely resemble the clinical hallmarks of SFN, our data suggest that transient overexpression of mutant human mRNA provides a model for SFN in zebrafish. This disease model may provide a basis for testing the pathogenicity of novel genetic variants identified in SFN patients. Furthermore, this model could be used for studying SFN pathophysiology in an in vivo model and for testing therapeutic interventions.

AB - Small-fiber neuropathy (SFN) patients experience a spectrum of sensory abnormalities, including attenuated responses to non-noxious temperatures in combination with a decreased density of the small-nerve fibers. Gain-of-function mutations in the voltage-gated sodium channels SCN9A, SCN10A and SCN11A have been identified as an underlying genetic cause in a subpopulation of patients with SFN. Based on clinical-diagnostic tests for SFN, we have set up a panel of two read-outs reflecting SFN in zebrafish, being nerve density and behavioral responses. Nerve density was studied using a transgenic line in which the sensory neurons are GFP-labelled. For the behavioral experiments, a temperature-controlled water compartment was developed. This device allowed quantification of the behavioral response to temperature changes. By using these read-outs we demonstrated that zebrafish embryos transiently overexpressing the pathogenic human SCN9A p.(I228M) or p.(G856D) mutations both have a significantly decreased density of the small-nerve fibers. Additionally, larvae overexpressing the p.(I228M) mutation displayed a significant increase in activity induced by temperature change. As these features closely resemble the clinical hallmarks of SFN, our data suggest that transient overexpression of mutant human mRNA provides a model for SFN in zebrafish. This disease model may provide a basis for testing the pathogenicity of novel genetic variants identified in SFN patients. Furthermore, this model could be used for studying SFN pathophysiology in an in vivo model and for testing therapeutic interventions.

KW - Nerve density

KW - SCN9A mutations

KW - Small-fiber neuropathy

KW - Temperature assay

KW - Zebrafish model

UR - http://www.scopus.com/inward/record.url?scp=85055679768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055679768&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2018.10.008

DO - 10.1016/j.expneurol.2018.10.008

M3 - Article

VL - 311

SP - 257

EP - 264

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

ER -